{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:24:50Z","timestamp":1790767490237,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"964","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic neuropathy (DN) refers to symptoms and signs of neuropathy in a patient with diabetes in whom other causes of neuropathy have been excluded. Distal symmetrical neuropathy is the commonest accounting for 75% DN. Asymmetrical neuropathies may involve cranial nerves, thoracic or limb nerves; are of acute onset resulting from ischaemic infarction of vasa nervosa. Asymmetric neuropathies in diabetic patients should be investigated for entrapment neuropathy. Diabetic amyotrophy, initially considered to result from metabolic changes, and later ischaemia, is now attributed to immunological changes. For diagnosis of DN, symptoms, signs, quantitative sensory testing, nerve conduction study, and autonomic testing are used; and two of these five are recommended for clinical diagnosis. Management of DN includes control of hyperglycaemia, other cardiovascular risk factors; \u03b1 lipoic acid and L carnitine. For neuropathic pain, analgesics, non-steroidal anti-inflammatory drugs, antidepressants, and anticonvulsants are recommended. The treatment of autonomic neuropathy is symptomatic.<\/jats:p>","DOI":"10.1136\/pgmj.2005.036137","type":"journal-article","created":{"date-parts":[[2006,2,3]],"date-time":"2006-02-03T11:38:37Z","timestamp":1138966717000},"page":"95-100","source":"Crossref","is-referenced-by-count":275,"title":["Diabetic neuropathy"],"prefix":"10.1093","volume":"82","author":[{"given":"V","family":"Bansal","sequence":"first","affiliation":[{"name":"Department of Neurology, Sanjay Gandhi PGIMS , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kalita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sanjay Gandhi PGIMS , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U K","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sanjay Gandhi PGIMS , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,2,3]]},"reference":[{"key":"2023042013494286800_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.diabres.2004.04.008","article-title":"The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS)","volume":"66","author":"Sadikot","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"2023042013494286800_bib2","volume-title":"Textbook of diabetes","author":"Pickup","year":"1991"},{"key":"2023042013494286800_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11892-004-0026-4","article-title":"Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian Indian epidemic","volume":"4","author":"Bajaj","year":"2004","journal-title":"Curr Diab Rep"},{"key":"2023042013494286800_bib4","first-page":"546","article-title":"Prevalence of neuropathy in type 2 diabetes patients attending diabetes center in South India","volume":"50","author":"Ashok","year":"2002","journal-title":"J Assoc Physicians India"},{"key":"2023042013494286800_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/diacare.19.7.751","article-title":"Natural progression of autonomic neuropathy and autonomic function tests in a cohort of IDDM","volume":"19","author":"Levitt","year":"1996","journal-title":"Diabetes Care"},{"key":"2023042013494286800_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1464-5491.1993.tb00173.x","article-title":"Mortality in diabetic patients with cardiovascular autonomic neuropathy","volume":"10","author":"Rathmann","year":"1993","journal-title":"Diabet Med"},{"key":"2023042013494286800_bib7","first-page":"245","article-title":"Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973 (third and last part)","volume":"3","author":"Pirart","year":"1977","journal-title":"Diabetes Metab"},{"key":"2023042013494286800_bib8","first-page":"19","article-title":"Diabetic Neuropathies","volume":"9","author":"Dyck","year":"2003","journal-title":"Continuum"},{"key":"2023042013494286800_bib9","first-page":"579","volume-title":"Nerve conduction in polyneuropathies","author":"Oh","year":"1993"},{"key":"2023042013494286800_bib10","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.280.21.1863","article-title":"Symptom treatment of painful neuropathy","volume":"280","author":"Low","year":"1998","journal-title":"JAMA"},{"key":"2023042013494286800_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00418349","article-title":"Arterio venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycemic control (insulin neuritis)","volume":"39","author":"Tesfaye","year":"1996","journal-title":"Diabetologia"},{"key":"2023042013494286800_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1742-1241.1998.tb08947.x","article-title":"Diabetic neuropathic cachexia\u2013the importance of positive recognition and early nutritional support","volume":"52","author":"Van Heel","year":"1998","journal-title":"Int J Clin Pract"},{"key":"2023042013494286800_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"key":"2023042013494286800_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mus.1136","article-title":"Painful sensory polyneuropathy associated with impaired glucose tolerance","volume":"24","author":"Singleton","year":"2001","journal-title":"Muscle Nerve"},{"key":"2023042013494286800_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ana.410020302","article-title":"Proximal diabetic neuropathy","volume":"2","author":"Asbury","year":"1977","journal-title":"Ann Neurol"},{"key":"2023042013494286800_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.10080","article-title":"Diabetic and non diabetic lumbosacral radiculoplexus neuropathies. New insights into pathophysiology and treatment","volume":"25","author":"Dyck","year":"2002","journal-title":"Muscle Nerve"},{"key":"2023042013494286800_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.1995.00540350039015","article-title":"Successful treatment of neuropathies in patients with diabetes mellitus","volume":"52","author":"Krendel","year":"1995","journal-title":"Arch Neurol"},{"key":"2023042013494286800_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4065\/72.12.1123","article-title":"Subacute diabetic proximal neuropathy","volume":"72","author":"Pascoe","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"2023042013494286800_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0304-3959(92)90085-P","article-title":"Acute and remitting diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology","volume":"48","author":"Brittand","year":"1992","journal-title":"Pain"},{"key":"2023042013494286800_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s001250050834","article-title":"Anti-ganglioside GM1 antibody and distal symmetric \u2018diabetic polyneuropathy\u2019 with dominant motor features","volume":"40","author":"Milicevic","year":"1997","journal-title":"Diabetologia"},{"key":"2023042013494286800_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.59.5.758","article-title":"Demyelinating neuropathy in diabetes mellitus","volume":"59","author":"Sharma","year":"2002","journal-title":"Arch Neurol"},{"key":"2023042013494286800_bib22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/01.WNL.0000058546.16985.11","article-title":"Quantitative sensory testing","volume":"602","author":"Shy","year":"2003","journal-title":"Neurology"},{"key":"2023042013494286800_bib23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.47.4.1042","article-title":"Quantitation of epidermal nerves in diabetic neuropathy","volume":"47","author":"Kennedy","year":"1996","journal-title":"Neurology"},{"key":"2023042013494286800_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00125-003-1086-8","article-title":"Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients","volume":"46","author":"Malik","year":"2003","journal-title":"Diabetologia"},{"key":"2023042013494286800_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2337\/diacare.11.7.592","article-title":"Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetic association, American Academy of Neurology","volume":"11","author":"Consensus statement","year":"1988","journal-title":"Diabetes Care"},{"key":"2023042013494286800_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.880110106","article-title":"Detection, characterization and staging of polyneuropathy: assessed in diabetes","volume":"11","author":"Dyck","year":"1988","journal-title":"Muscle Nerve"},{"issue":"suppl 2","key":"2023042013494286800_bib27","first-page":"A71","article-title":"Physician perception of neuropathy in a large diabetes type 2 populations (GOAL AIC study) confirms under diagnosis of neuropathy in everyday clinical practice","volume":"46","author":"Herman","year":"2003","journal-title":"Diabetologia"},{"key":"2023042013494286800_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1520-6769(199707)21:1<13::AID-NRC203>3.0.CO;2-P","article-title":"The use of electrophysiology for the assessment of diabetic neuropathy","volume":"21","author":"Arezzo","year":"1997","journal-title":"Neurosci Res Comm"},{"key":"2023042013494286800_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus","volume":"333","author":"Partanen","year":"1995","journal-title":"N Engl J Med"},{"key":"2023042013494286800_bib30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1464-5491.1991.tb01530.x","article-title":"The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy","volume":"8","author":"Venes","year":"1991","journal-title":"Diabet Med"},{"key":"2023042013494286800_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-122-8-199504150-00001","article-title":"The effect of intensive diabetes therapy on the development and progression of neuropathy","volume":"122","author":"DCCT Research group","year":"1995","journal-title":"Ann Intern Med"},{"key":"2023042013494286800_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPD S38","volume":"317","author":"UK Prospective Diabetes study Group","year":"1998","journal-title":"BMJ"},{"key":"2023042013494286800_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"2023042013494286800_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"2023042013494286800_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1056-8727(97)00121-9","article-title":"Effect of Aldose reductase inhibition on cardiovascular reflex tests in patients with definite diabetic autonomic neuropathy","volume":"12","author":"Didangelos","year":"1998","journal-title":"J Diabetes Complications"},{"key":"2023042013494286800_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.53.3.580","article-title":"Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group","volume":"53","author":"Greene","year":"1999","journal-title":"Neurology"},{"key":"2023042013494286800_bib37","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2337\/diacare.22.8.1296","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7 month multicentre randomized controlled trial (ALADIN III study). ALADIN III study group. Alpha- lipoic acid in diabetic neuropathy","volume":"22","author":"Ziegler","year":"1999","journal-title":"Diabetes Care"},{"key":"2023042013494286800_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/diacare.16.1.8","article-title":"Treatment of diabetic neuropathy with \u03b3 Linolenic acid","volume":"16","author":"Keen","year":"1993","journal-title":"Diabetes Care"},{"key":"2023042013494286800_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl L Carnitine improves pain, nerve regeneration and vibratory perception in patients with chronic diabetic neuropathy","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"key":"2023042013494286800_bib40","first-page":"593","article-title":"Neurotropic factors in the therapy of peripheral neuropathy","volume":"4","author":"Apfel","year":"1995","journal-title":"Baillieres Clinical Neuropathy"},{"key":"2023042013494286800_bib41","first-page":"A54","article-title":"Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rh NGF)","volume":"48","author":"Vinik","year":"1999","journal-title":"Diabetes"},{"key":"2023042013494286800_bib42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI12188","article-title":"Reversal of experimental diabetic neuropathy by VEGF gene transfer","volume":"107","author":"Schratzberger","year":"2001","journal-title":"J Clin Invest"},{"key":"2023042013494286800_bib43","volume-title":"Cochrane Library","author":"Wiffen","year":"2000"},{"key":"2023042013494286800_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"2023042013494286800_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s004150050179","article-title":"Uncommon early onset neuropathy in diabetic patients","volume":"245","author":"Said","year":"1998","journal-title":"J Neurol"},{"key":"2023042013494286800_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"2023042013494286800_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"key":"2023042013494286800_bib48","first-page":"A130","article-title":"Topiramate improves C fibre neuropathy and features of dysmetabolic syndrome in type 2 diabetes mellitus","volume":"52","author":"Vinik","year":"2003","journal-title":"Diabetes"},{"key":"2023042013494286800_bib49","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archinte.1987.00370080078016","article-title":"Efficacy and safety of non steroidal anti-inflammatory drugs in the therapy of diabetic neuropathy","volume":"147","author":"Cohen","year":"1987","journal-title":"Arch Intern Med"},{"key":"2023042013494286800_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0140-6736(90)92005-3","article-title":"Calcitonin nasal spray for painful diabetic neuropathy","volume":"336","author":"Zieleniewski","year":"1990","journal-title":"Lancet"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/82\/964\/95\/50024670\/postgradmedj-82-95.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/82\/964\/95\/50024670\/postgradmedj-82-95.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T13:10:40Z","timestamp":1706879440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/82\/964\/95\/7045246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":50,"journal-issue":{"issue":"964","published-online":{"date-parts":[[2006,2,3]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2005.036137","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2006,2,1]]}}}